Browse By Oncolytic Virus Species Result Page of OvirusTdb

The Total number of records shown on this page is 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_1AdenovirusoAd/DCN/LRPDNAAdenoviridaeInsertional mutant for DCN and LRP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-1Grown to 70% confluenceNAMTT assay50 MOI59% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysIL-6 production increased by 3 folds as compared to normalNA26471393
OV_2AdenovirusoAd/DCN/LRPDNAAdenoviridaeInsertional mutant for DCN and LRP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-1Grown to 70% confluenceNAMTT assay100 MOI56% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysIL-6 production increased by 3 folds as compared to normalNA26471393
OV_3AdenovirusoAd/DCN/LRPDNAAdenoviridaeInsertional mutant for DCN and LRP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-1Grown to 70% confluenceNAMTT assay200 MOI49% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysIL-6 production increased by 3 folds as compared to normalNA26471393
OV_4AdenovirusoAd/DCN/LRP-PEGDNAAdenoviridaeInsertional mutant for DCN and LRP gene with polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell linePANC-1Grown to 70% confluenceNAMTT assay50 MOI90% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_5AdenovirusoAd/DCN/LRP-PEGDNAAdenoviridaeInsertional mutant for DCN and LRP gene with polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell linePANC-1Grown to 70% confluenceNAMTT assay100 MOI78% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_6AdenovirusoAd/DCN/LRP-PEGDNAAdenoviridaeInsertional mutant for DCN and LRP gene with polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell linePANC-1Grown to 70% confluenceNAMTT assay200 MOI78% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_7AdenovirusoAd/DCN/LRP-PEG-NTDNAAdenoviridaeInsertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell linePANC-1Grown to 70% confluenceNAMTT assay50 MOI70% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_8AdenovirusoAd/DCN/LRP-PEG-NTDNAAdenoviridaeInsertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell linePANC-1Grown to 70% confluenceNAMTT assay100 MOI60% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_9AdenovirusoAd/DCN/LRP-PEG-NTDNAAdenoviridaeInsertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell linePANC-1Grown to 70% confluenceNAMTT assay200 MOI38% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_10AdenovirusoAd/DCN/LRPDNAAdenoviridaeInsertional mutant for DCN and LRP geneYesNoNoATCCHuman pancreatic cancer cell lineMIAPaCa-2Grown to 70% confluenceNAMTT assay10 MOI70% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysIL-6 production increased by 3 folds as compared to normalNA26471393
OV_11AdenovirusoAd/DCN/LRPDNAAdenoviridaeInsertional mutant for DCN and LRP geneYesNoNoATCCHuman pancreatic cancer cell lineMIAPaCa-2Grown to 70% confluenceNAMTT assay50 MOI58% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysIL-6 production increased by 3 folds as compared to normalNA26471393
OV_12AdenovirusoAd/DCN/LRPDNAAdenoviridaeInsertional mutant for DCN and LRP geneYesNoNoATCCHuman pancreatic cancer cell lineMIAPaCa-2Grown to 70% confluenceNAMTT assay100 MOI38% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysIL-6 production increased by 3 folds as compared to normalNA26471393
OV_13AdenovirusoAd/DCN/LRP-PEGDNAAdenoviridaeInsertional mutant for DCN and LRP gene with polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell lineMIAPaCa-2Grown to 70% confluenceNAMTT assay10 MOI100% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_14AdenovirusoAd/DCN/LRP-PEGDNAAdenoviridaeInsertional mutant for DCN and LRP gene with polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell lineMIAPaCa-2Grown to 70% confluenceNAMTT assay50 MOI95% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_15AdenovirusoAd/DCN/LRP-PEGDNAAdenoviridaeInsertional mutant for DCN and LRP gene with polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell lineMIAPaCa-2Grown to 70% confluenceNAMTT assay100 MOI94% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_16AdenovirusoAd/DCN/LRP-PEG-NTDNAAdenoviridaeInsertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell lineMIAPaCa-2Grown to 70% confluenceNAMTT assay10 MOI77% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_17AdenovirusoAd/DCN/LRP-PEG-NTDNAAdenoviridaeInsertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell lineMIAPaCa-2Grown to 70% confluenceNAMTT assay50 MOI72% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_18AdenovirusoAd/DCN/LRP-PEG-NTDNAAdenoviridaeInsertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell lineMIAPaCa-2Grown to 70% confluenceNAMTT assay100 MOI58% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_19AdenovirusoAd/DCN/LRPDNAAdenoviridaeInsertional mutant for DCN and LRP geneYesNoNoATCCHuman lung cancer cell lineA549Grown to 70% confluenceNAMTT assay1 MOI70% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysIL-6 production increased by 3 folds as compared to normalNA26471393
OV_20AdenovirusoAd/DCN/LRPDNAAdenoviridaeInsertional mutant for DCN and LRP geneYesNoNoATCCHuman lung cancer cell lineA549Grown to 70% confluenceNAMTT assay5 MOI58% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysIL-6 production increased by 3 folds as compared to normalNA26471393
OV_21AdenovirusoAd/DCN/LRPDNAAdenoviridaeInsertional mutant for DCN and LRP geneYesNoNoATCCHuman lung cancer cell lineA549Grown to 70% confluenceNAMTT assay10 MOI38% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysIL-6 production increased by 3 folds as compared to normalNA26471393
OV_22AdenovirusoAd/DCN/LRP-PEGDNAAdenoviridaeInsertional mutant for DCN and LRP gene with polyethylene glycolYesNoNoATCCHuman lung cancer cell lineA549Grown to 70% confluenceNAMTT assay1 MOI100% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_23AdenovirusoAd/DCN/LRP-PEGDNAAdenoviridaeInsertional mutant for DCN and LRP gene with polyethylene glycolYesNoNoATCCHuman lung cancer cell lineA549Grown to 70% confluenceNAMTT assay5 MOI95% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_24AdenovirusoAd/DCN/LRP-PEGDNAAdenoviridaeInsertional mutant for DCN and LRP gene with polyethylene glycolYesNoNoATCCHuman lung cancer cell lineA549Grown to 70% confluenceNAMTT assay10 MOI94% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_25AdenovirusoAd/DCN/LRP-PEG-NTDNAAdenoviridaeInsertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycolYesNoNoATCCHuman lung cancer cell lineA549Grown to 70% confluenceNAMTT assay1 MOI77% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_26AdenovirusoAd/DCN/LRP-PEG-NTDNAAdenoviridaeInsertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycolYesNoNoATCCHuman lung cancer cell lineA549Grown to 70% confluenceNAMTT assay5 MOI72% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_27AdenovirusoAd/DCN/LRP-PEG-NTDNAAdenoviridaeInsertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycolYesNoNoATCCHuman lung cancer cell lineA549Grown to 70% confluenceNAMTT assay10 MOI58% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_28AdenovirusoAd/DCN/LRPDNAAdenoviridaeInsertional mutant for DCN and LRP geneYesNoNoATCCHuman pancreatic cancer cell lineAsPC-1Grown to 70% confluenceNAMTT assay5 MOI80% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysIL-6 production increased by 3 folds as compared to normalNA26471393
OV_29AdenovirusoAd/DCN/LRPDNAAdenoviridaeInsertional mutant for DCN and LRP geneYesNoNoATCCHuman pancreatic cancer cell lineAsPC-1Grown to 70% confluenceNAMTT assay10 MOI78% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysIL-6 production increased by 3 folds as compared to normalNA26471393
OV_30AdenovirusoAd/DCN/LRPDNAAdenoviridaeInsertional mutant for DCN and LRP geneYesNoNoATCCHuman pancreatic cancer cell lineAsPC-1Grown to 70% confluenceNAMTT assay20 MOI40% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysIL-6 production increased by 3 folds as compared to normalNA26471393
OV_31AdenovirusoAd/DCN/LRP-PEGDNAAdenoviridaeInsertional mutant for DCN and LRP gene with polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell lineAsPC-1Grown to 70% confluenceNAMTT assay5 MOI90% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_32AdenovirusoAd/DCN/LRP-PEGDNAAdenoviridaeInsertional mutant for DCN and LRP gene with polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell lineAsPC-1Grown to 70% confluenceNAMTT assay10 MOI82% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_33AdenovirusoAd/DCN/LRP-PEGDNAAdenoviridaeInsertional mutant for DCN and LRP gene with polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell lineAsPC-1Grown to 70% confluenceNAMTT assay20 MOI84% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_34AdenovirusoAd/DCN/LRP-PEG-NTDNAAdenoviridaeInsertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell lineAsPC-1Grown to 70% confluenceNAMTT assay5 MOI89% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_35AdenovirusoAd/DCN/LRP-PEG-NTDNAAdenoviridaeInsertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell lineAsPC-1Grown to 70% confluenceNAMTT assay10 MOI94% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_36AdenovirusoAd/DCN/LRP-PEG-NTDNAAdenoviridaeInsertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycolYesNoNoATCCHuman pancreatic cancer cell lineAsPC-1Grown to 70% confluenceNAMTT assay20 MOI94% cancer cell viabilityNoNoNA No responseNAInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_37AdenovirusoAd/DCN/LRPDNAAdenoviridaeInsertional mutant for DCN and LRP geneYesNoNoNANANANANANANANABALB/c nude mice xenograft for MIA PaCa-2 cell line 5.0E+6 cells2.0E+10 VP (on 0, 2, and 4 days)Slight hepatotoxicity Reduction in tumor volume to 230 cubic millimeter compared to control 300 cubic millimeter after 46 daysIntravenouslyInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysIL-6 production increased by 3 folds as compared to normalNA26471393
OV_38AdenovirusoAd/DCN/LRP-PEGDNAAdenoviridaeInsertional mutant for DCN and LRP gene with polyethylene glycolYesNoNoNANANANANANANANABALB/c nude mice xenograft for MIA PaCa-2 cell line 5.0E+4 cells2.0E+10 VP (on 0, 2, and 4 days)NA Reduction in tumor volume to 198 cubic millimeter compared to control 300 cubic millimeter after 46 daysIntravenouslyInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_39AdenovirusoAd/DCN/LRP-PEG-NTDNAAdenoviridaeInsertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycolYesNoNoNANANANANANANANABALB/c nude mice xenograft for MIA PaCa-2 cell line 5.0E+4 cells2.0E+10 VP (on 0, 2, and 4 days)NA Reduction in tumor volume to 100 cubic millimeter compared to control 300 cubic millimeter after 46 daysIntravenouslyInhibits Wnt/β-catenin and TGF-β1 signaling pathwaysNANA26471393
OV_40AdenovirusAdCMV/GFPDNAAdenoviridaeMutant with E1 deletion carrying a green fluorescent protein (GFP)YesNoNoATCCHuman lung cancer cell lineA549Desnity of 1000000 in 60mm dishHighly toxic to NIH/3T3 as measured by crystal violet staining at 10 MOIMTT assay3.5 MOI13% cancer cell viabilityNoNoNA No responseNANANANA26475304
OV_41AdenovirusAd dl1520DNAAdenoviridaeE1b mutant with 827-bp deletion and a point mutation with premature stop codon in the E1B55K coding regionYesNoNoATCCHuman lung cancer cell lineA549Desnity of 1000000 in 60mm dishMinimal toxic to NIH/3T3 as measured by crystal violet staining at 10 MOIMTT assay3.5 MOI54% cancer cell viabilityNoNoNA No responseNANANANA26475304
OV_42AdenovirusAd-cycEDNAAdenoviridaeE1b-deleted mutant with a human cyclin E promoter driving an intact E1A expression cassetteYesNoNoATCCHuman lung cancer cell lineA549Desnity of 1000000 in 60mm dishMinimal toxic to NIH/3T3 as measured by crystal violet staining at 10 MOIMTT assay3.5 MOI18% cancer cell viabilityNoNoNA No responseNANAActivates CDK2 and targets the transcriptional repressor pRbNA26475304
OV_43AdenovirusAdCMV/GFPDNAAdenoviridaeMutant with E1 deletion carrying a green fluorescent protein (GFP)YesNoNoATCCMurine lung cancer cell lineED-1Desnity of 1000000 in 60mm dishHighly toxic to NIH/3T3 as measured by crystal violet staining at 10 MOIMTT assay10 MOI22% cancer cell viabilityNoNoNA No responseNANANANA26475304
OV_44AdenovirusAd dl1520DNAAdenoviridaeE1b mutant with 827-bp deletion and a point mutation with premature stop codon in the E1B55K coding regionYesNoNoATCCMurine lung cancer cell lineED-1Desnity of 1000000 in 60mm dishMinimal toxic to NIH/3T3 as measured by crystal violet staining at 10 MOIMTT assay10 MOI55% cancer cell viabilityNoNoNA No responseNANANANA26475304
OV_45AdenovirusAd-cycEDNAAdenoviridaeE1b-deleted mutant with a human cyclin E promoter driving an intact E1A expression cassetteYesNoNoATCCMurine lung cancer cell lineED-1Desnity of 1000000 in 60mm dishMinimal toxic to NIH/3T3 as measured by crystal violet staining at 10 MOIMTT assay10 MOI55% cancer cell viabilityNoNoNA No responseNANAActivates CDK2 and targets the transcriptional repressor pRbNA26475304
OV_46AdenovirusAd-cycEDNAAdenoviridaeE1b-deleted mutant with a human cyclin E promoter driving an intact E1A expression cassetteYesNoNoNANANANANANANANAFemale FVB/NCr mice isograft for 5.0E+6 cells ED-1 murine lung cancer cell lines1.5E+9 IFU (on 0, 2, 4 and 6 days)NA Reduction in tumor volume to 52 cubic millimeter compared to control 150 cubic millimeter after 36 daysIntratumorallyNAActivates CDK2 and targets the transcriptional repressor pRbNA26475304
OV_47AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman lung cancer cell lineA5491.0E+6 cells per wellNAMTT assay0.1 MOI57% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_48AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterNoViral strain in combination with etoposide (0.5 μg/ml)NoNAHuman lung cancer cell lineA5491.0E+6 cells per well0.67 CDIMTT assay0.1 MOI24% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_49AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterNoViral strain in combination with epirubicin (0.5 μg/ml)NoNAHuman lung cancer cell lineA5491.0E+6 cells per well0.46 CDIMTT assay0.1 MOI16% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_50AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterNoViral strain in combination with doxorubicin (0.1 μg/ml)NoNAHuman lung cancer cell lineA5491.0E+6 cells per well0.88 CDIMTT assay0.1 MOI26% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_51AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterNoViral strain in combination with vincristine (0.1 μg/ml)NoNAHuman lung cancer cell lineA5491.0E+6 cells per well0.79 CDIMTT assay0.1 MOI25% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_52AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterNoViral strain in combination with colchcine (0.02 μg/ml)NoNAHuman lung cancer cell lineA5491.0E+6 cells per well0.81 CDIMTT assay0.1 MOI28% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_53AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman lung cancer cell lineA5491.0E+6 cells per wellNAMTT assay0.1 MOI18% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_54AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterNoViral strain in combination with etoposide (0.5 μg/ml)NoNAHuman lung cancer cell lineA5491.0E+6 cells per well0.27 CDIMTT assay0.1 MOI4% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_55AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterNoViral strain in combination with epirubicin (0.5 μg/ml)NoNAHuman lung cancer cell lineA5491.0E+6 cells per well0.31 CDIMTT assay0.1 MOI4% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_56AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterNoViral strain in combination with doxorubicin (0.1 μg/ml)NoNAHuman lung cancer cell lineA5491.0E+6 cells per well0.33 CDIMTT assay0.1 MOI6% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_57AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterNoViral strain in combination with vincristine (0.1 μg/ml)NoNAHuman lung cancer cell lineA5491.0E+6 cells per well0.89 CDIMTT assay0.1 MOI12% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_58AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterNoViral strain in combination with colchcine (0.02 μg/ml)NoNAHuman lung cancer cell lineA5491.0E+6 cells per well0.78 CDIMTT assay0.1 MOI10% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_59AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (YB-1 gene knockdown)NANACrystal violet staining0.01 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_60AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (YB-1 gene knockdown)NANACrystal violet staining0.1 MOI90% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_61AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (YB-1 gene knockdown)NANACrystal violet staining1 MOI40% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_62AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (YB-1 gene knockdown)NANACrystal violet staining10 MOI2% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_63AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining0.001 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_64AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining0.01 MOI90% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_65AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining0.1 MOI60% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_66AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining1 MOI4% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_67AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining10 MOI1% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_68AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining0.001 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_69AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining0.01 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_70AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining0.1 MOI96% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_71AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining1 MOI80% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_72AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining10 MOI20% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_73AdenovirusAdLacZDNAAdenoviridaeE1/E3-deleted mutantYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining0.01 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_74AdenovirusAdLacZDNAAdenoviridaeE1/E3-deleted mutantYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining0.1 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_75AdenovirusAdLacZDNAAdenoviridaeE1/E3-deleted mutantYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining1 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_76AdenovirusAdLacZDNAAdenoviridaeE1/E3-deleted mutantYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining10 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_77AdenovirusAdLacZDNAAdenoviridaeE1/E3-deleted mutantYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining0.01 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_78AdenovirusAdLacZDNAAdenoviridaeE1/E3-deleted mutantYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining0.1 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_79AdenovirusAdLacZDNAAdenoviridaeE1/E3-deleted mutantYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining1 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_80AdenovirusAdLacZDNAAdenoviridaeE1/E3-deleted mutantYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining10 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_81AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (YB-1 gene knockdown)NANACrystal violet staining0.01 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_82AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (YB-1 gene knockdown)NANACrystal violet staining0.1 MOI85% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_83AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (YB-1 gene knockdown)NANACrystal violet staining1 MOI35% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_84AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (YB-1 gene knockdown)NANACrystal violet staining10 MOI1% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_85AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining0.001 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_86AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining0.01 MOI90% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_87AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining0.1 MOI20% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_88AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining1 MOI2% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_89AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining10 MOI1% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_90AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining0.001 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_91AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining0.01 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_92AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining0.1 MOI94% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_93AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining1 MOI75% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_94AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining10 MOI16% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_95AdenovirusAdLacZDNAAdenoviridaeE1/E3-deleted mutantYesNoNoNANANANANANANANAClinical lung adenocarcinoma tissue (Primary cancer cells, Stage IA)0.01 MOINA 100% cancer cell viabilityNANANANA26515462
OV_96AdenovirusAdLacZDNAAdenoviridaeE1/E3-deleted mutantYesNoNoNANANANANANANANAClinical lung adenocarcinoma tissue (Primary cancer cells, Stage IA)0.1 MOINA 100% cancer cell viabilityNANANANA26515462
OV_97AdenovirusAdLacZDNAAdenoviridaeE1/E3-deleted mutantYesNoNoNANANANANANANANAClinical lung adenocarcinoma tissue (Primary cancer cells, Stage IA)1 MOINA 100% cancer cell viabilityNANANANA26515462
OV_98AdenovirusAdLacZDNAAdenoviridaeE1/E3-deleted mutantYesNoNoNANANANANANANANAClinical lung adenocarcinoma tissue (Primary cancer cells, Stage IA)10 MOINA 100% cancer cell viabilityNANANANA26515462
OV_99AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNANANANANANANANAClinical lung adenocarcinoma tissue (Primary cancer cells, Stage IA)0.01 MOINA 100% cancer cell viabilityNANANANA26515462
OV_100AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNANANANANANANANAClinical lung adenocarcinoma tissue (Primary cancer cells, Stage IA)0.1 MOINA 100% cancer cell viabilityNANANANA26515462